ReviewACS omega2025
Spatial Detection of Pb in Life Sciences: Advances and Limitations.
Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lead (Pb) is a significant worldwide environmental contaminant. Elevated blood-lead levels during childhood can affect development and are associated with cognitive impairments, learning disabilities, and attentional deficits later in life. Clinical and toxicological assessments of Pb exposure are generally limited to blood lead level (BLL) tests. BLLs are a transient measure of Pb, as Pb itself distributes and deposits all throughout the body, including all major organs, bones, and the central nervous system. Understanding how BLLs relate to systemic and cellular Pb uptake is crucial for guiding treatments and therapies, yet tissue biopsies of the nervous system in otherwise healthy patients are often infeasible. Researchers have access to controlled experimental models to determine causal actions of Pb but are currently faced with limited options and techniques due to access and cost. While there have been many advances in spatial Pb detection since the early 1900s, they have not always translated to biological sciences as naturally as other research areas, such as geology or material sciences. We propose this is largely because of sample preparation, sample size, and imaging parameters (e.g., depth, scanning area, etc.). There is an urgent need for awareness of this gap in technology and the utility it will play in advancing our knowledge of Pb-induced health conditions. In this review, we discuss the various methods used to spatially detect and visualize Pb within biological samples, with special emphasis on the lack of tractable Pb detection techniques capable of generating spatial information in biological samples. We also discuss modern developments and advancements, emerging techniques in Pb detection, and suggested applications for future research endeavors.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.